Literature DB >> 35474479

Fragment screening and structural analyses highlight the ATP-assisted ligand binding for inhibitor discovery against type 1 methionyl-tRNA synthetase.

Jia Yi1,2, Zhengjun Cai1,2, Haipeng Qiu1,2, Feihu Lu1,2, Zhiteng Luo1,2, Bingyi Chen1,2, Qiong Gu2, Jun Xu2, Huihao Zhou1,2.   

Abstract

Methionyl-tRNA synthetase (MetRS) charges tRNAMet with l-methionine (L-Met) to decode the ATG codon for protein translation, making it indispensable for all cellular lives. Many gram-positive bacteria use a type 1 MetRS (MetRS1), which is considered a promising antimicrobial drug target due to its low sequence identity with human cytosolic MetRS (HcMetRS, which belongs to MetRS2). Here, we report crystal structures of a representative MetRS1 from Staphylococcus aureus (SaMetRS) in its apo and substrate-binding forms. The connecting peptide (CP) domain of SaMetRS differs from HcMetRS in structural organization and dynamic movement. We screened 1049 chemical fragments against SaMetRS preincubated with or without substrate ATP, and ten hits were identified. Four cocrystal structures revealed that the fragments bound to either the L-Met binding site or an auxiliary pocket near the tRNA CCA end binding site of SaMetRS. Interestingly, fragment binding was enhanced by ATP in most cases, suggesting a potential ATP-assisted ligand binding mechanism in MetRS1. Moreover, co-binding with ATP was also observed in our cocrystal structure of SaMetRS with a class of newly reported inhibitors that simultaneously occupied the auxiliary pocket, tRNA site and L-Met site. Our findings will inspire the development of new MetRS1 inhibitors for fighting microbial infections.
© The Author(s) 2022. Published by Oxford University Press on behalf of Nucleic Acids Research.

Entities:  

Year:  2022        PMID: 35474479      PMCID: PMC9071491          DOI: 10.1093/nar/gkac285

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   19.160


  63 in total

1.  Optimisation of aryl substitution leading to potent methionyl tRNA synthetase inhibitors with excellent gram-positive antibacterial activity.

Authors:  Richard L Jarvest; John M Berge; Murray J Brown; Pamela Brown; John S Elder; Andrew K Forrest; C S V Houge-Frydrych; Peter J O'Hanlon; David J McNair; Stephen Rittenhouse; Robert J Sheppard
Journal:  Bioorg Med Chem Lett       Date:  2003-02-24       Impact factor: 2.823

2.  Mode of action and biochemical characterization of REP8839, a novel inhibitor of methionyl-tRNA synthetase.

Authors:  Urs A Ochsner; Casey L Young; Kimberley C Stone; Frank B Dean; Nebojsa Janjic; Ian A Critchley
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

3.  Structure of Leishmania major methionyl-tRNA synthetase in complex with intermediate products methionyladenylate and pyrophosphate.

Authors:  Eric T Larson; Jessica E Kim; Frank H Zucker; Angela Kelley; Natascha Mueller; Alberto J Napuli; Christophe L M J Verlinde; Erkang Fan; Frederick S Buckner; Wesley C Van Voorhis; Ethan A Merritt; Wim G J Hol
Journal:  Biochimie       Date:  2010-12-07       Impact factor: 4.079

4.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

5.  Variable sensitivity to bacterial methionyl-tRNA synthetase inhibitors reveals subpopulations of Streptococcus pneumoniae with two distinct methionyl-tRNA synthetase genes.

Authors:  Daniel R Gentry; Karen A Ingraham; Michael J Stanhope; Stephen Rittenhouse; Richard L Jarvest; Peter J O'Hanlon; James R Brown; David J Holmes
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

6.  Horizontal transfer of drug-resistant aminoacyl-transfer-RNA synthetases of anthrax and Gram-positive pathogens.

Authors:  James R Brown; Daniel Gentry; Julie A Becker; Karen Ingraham; David J Holmes; Michael J Stanhope
Journal:  EMBO Rep       Date:  2003-07       Impact factor: 8.807

7.  Molecular basis for diaryldiamine selectivity and competition with tRNA in a type 2 methionyl-tRNA synthetase from a Gram-negative bacterium.

Authors:  Gustavo Fernando Mercaldi; Maxuel de Oliveira Andrade; Jackeline de Lima Zanella; Artur Torres Cordeiro; Celso Eduardo Benedetti
Journal:  J Biol Chem       Date:  2021-04-12       Impact factor: 5.157

8.  Prioritizing multiple therapeutic targets in parallel using automated DNA-encoded library screening.

Authors:  Carl A Machutta; Christopher S Kollmann; Kenneth E Lind; Xiaopeng Bai; Pan F Chan; Jianzhong Huang; Lluis Ballell; Svetlana Belyanskaya; Gurdyal S Besra; David Barros-Aguirre; Robert H Bates; Paolo A Centrella; Sandy S Chang; Jing Chai; Anthony E Choudhry; Aaron Coffin; Christopher P Davie; Hongfeng Deng; Jianghe Deng; Yun Ding; Jason W Dodson; David T Fosbenner; Enoch N Gao; Taylor L Graham; Todd L Graybill; Karen Ingraham; Walter P Johnson; Bryan W King; Christopher R Kwiatkowski; Joël Lelièvre; Yue Li; Xiaorong Liu; Quinn Lu; Ruth Lehr; Alfonso Mendoza-Losana; John Martin; Lynn McCloskey; Patti McCormick; Heather P O'Keefe; Thomas O'Keeffe; Christina Pao; Christopher B Phelps; Hongwei Qi; Keith Rafferty; Genaro S Scavello; Matt S Steiginga; Flora S Sundersingh; Sharon M Sweitzer; Lawrence M Szewczuk; Amy Taylor; May Fern Toh; Juan Wang; Minghui Wang; Devan J Wilkins; Bing Xia; Gang Yao; Jean Zhang; Jingye Zhou; Christine P Donahue; Jeffrey A Messer; David Holmes; Christopher C Arico-Muendel; Andrew J Pope; Jeffrey W Gross; Ghotas Evindar
Journal:  Nat Commun       Date:  2017-07-17       Impact factor: 14.919

9.  Antibiotic resistance: Global health crisis and metagenomics.

Authors:  Shailendra Yadav; Atya Kapley
Journal:  Biotechnol Rep (Amst)       Date:  2021-02-23

10.  X-shaped structure of bacterial heterotetrameric tRNA synthetase suggests cryptic prokaryote functions and a rationale for synthetase classifications.

Authors:  Yingchen Ju; Lu Han; Bingyi Chen; Zhiteng Luo; Qiong Gu; Jun Xu; Xiang-Lei Yang; Paul Schimmel; Huihao Zhou
Journal:  Nucleic Acids Res       Date:  2021-09-27       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.